ated doses and adjuvants 12,14
Viral vector vaccines Safety; induces high cellular and humoral immune responses Possibly present pre-existing immunity 12
DNA vaccines Easier to design; high safety; high-titer neutralizing antibodies Lower immune responses in humans; repea